Below is Validea's guru fundamental report for VERTEX PHARMACEUTICALS INC (VRTX). Of the 22 guru strategies we follow, VRTX rates highest using our P/B Growth Investor model based on the published ...

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the JPMorgan Nasdaq Equity Premium Income ETF (Symbol: JEPQ) where we ...

Below is Validea's guru fundamental report for VERTEX PHARMACEUTICALS INC (VRTX). Of the 22 guru strategies we follow, VRTX rates highest using our P/B Growth Investor model based on the published ...

In the latest close session, Vertex Pharmaceuticals (VRTX) was down 1% at $455.45. This change was narrower than the S&P 500's daily loss of 1.13%. Elsewhere, the Dow lost 1.79%, while the tech ...

Discover real-time Vertex Pharmaceuticals Incorporated Common Stock (VRTX) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with ...

Parnassus Investments, an investment management company, released the “Parnassus Growth Equity Fund” first quarter 2025 ...

Nasdaq Listed Nasdaq 100 Alerts Market: Closed Vertex Pharmaceuticals Incorporated Common Stock (VRTX) Volume: 1,169,253 52 Week Range: 377.85 - 519.88 ...

Nasdaq Listed Nasdaq 100 Alerts Market: Open Vertex Pharmaceuticals Incorporated Common Stock (VRTX) Bid: $447.79 X 42 Ask: $448.20 X 100 Volume: 210,695 ...

Throughout the last three months, 10 analysts have evaluated Vertex Pharmaceuticals (NASDAQ: VRTX), offering a diverse set of opinions from bullish to bearish. The table below offers a condensed ...

While VRTX is responsible for recording all product sales, CRSP records its share of Casgevy’s profits/losses. While Casgevy is the first-ever approved CRISPR/Cas9 gene-edited therapy, its ...

Vertex Pharmaceuticals Incorporated Common Stock (VRTX) Volume: 1,505,319 52 Week Range: 377.85 - 519.88 ...